Eledon Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
/ 
Frequently asked questions
To buy Eledon Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Eledon Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Eledon Pharmaceuticals Inc. is ELDN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Eledon Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Eledon Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Eledon Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Eledon Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Eledon Pharmaceuticals Inc..